One more detail is that Glioblast was registered only months before this deal. So its fair to say this payment may be brokerage. It makes it sound like this was a bio company and yes technically is correct. The thing since this Paul Hopper deal there have been no other deals in 5 years it seems the whole company rides on the back of one deal with Hopper.
Having said that the guy is having lots of success. Maybe its a good deal but if you see his youtube videos he is very critical of some things. Worth a look.
With Platinum its just a rebalance of the portfolio they may be legally required to limit certain exposures in the interests of thier clients. This is a high risk speculation so a professional cannot do things like some and have dangerous weightings into KZA.
I have some exposure to Platinum full disclosure.
Good luck.
- Forums
- ASX - By Stock
- KZA
- Kazia Share Price
Kazia Share Price, page-498
-
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online